Cargando…

Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression

It is now well established that the enzymes phosphoinositide 3-kinases (PI3Ks) have a key role in the development and progression of many cancer types and indeed PI3Ks inhibitors are currently being tested in clinical trials. Although eight distinct PI3K isoforms exist, grouped into three classes, m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chikh, Anissa, Ferro, Riccardo, Abbott, Jonathan J., Piñeiro, Roberto, Buus, Richard, Iezzi, Manuela, Ricci, Francesca, Bergamaschi, Daniele, Ostano, Paola, Chiorino, Giovanna, Lattanzio, Rossano, Broggini, Massimo, Piantelli, Mauro, Maffucci, Tania, Falasca, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951291/ https://www.ncbi.nlm.nih.gov/pubmed/26934321 http://dx.doi.org/10.18632/oncotarget.7761

Ejemplares similares

Phosphoinositide 3-kinase class II beta is a novel target in breast cancer therapy
por: Abbott, J, et al.
Publicado: (2010)

Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer
por: Emmanouilidi, Aikaterini, et al.
Publicado: (2019)

Class II Phosphoinositide 3-Kinases Contribute to Endothelial Cells Morphogenesis
por: Tibolla, Gianpaolo, et al.
Publicado: (2013)

Inositol Polyphosphate-Based Compounds as Inhibitors of Phosphoinositide 3-Kinase-Dependent Signaling
por: Maffucci, Tania, et al.
Publicado: (2020)

Novel roles for class II Phosphoinositide 3-Kinase C2β in signalling pathways involved in prostate cancer cell invasion
por: Mavrommati, Ioanna, et al.
Publicado: (2016)

Class II phosphoinositide 3-kinase defines a novel signaling pathway in cell migration
por: Maffucci, Tania, et al.
Publicado: (2005)

Downregulation of class II phosphoinositide 3-kinase PI3K-C2β delays cell division and potentiates the effect of docetaxel on cancer cell growth
por: Cisse, Ouma, et al.
Publicado: (2019)

PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes
por: Lattanzio, Rossano, et al.
Publicado: (2019)

Class II Phosphoinositide 3-Kinase Regulates Exocytosis of Insulin Granules in Pancreatic β Cells
por: Dominguez, Veronica, et al.
Publicado: (2011)

A Phosphoinositide 3-Kinase/Phospholipase Cgamma1 Pathway Regulates Fibroblast Growth Factor-Induced Capillary Tube Formation
por: Maffucci, Tania, et al.
Publicado: (2009)

Targeting p110gamma in gastrointestinal cancers: attack on multiple fronts
por: Falasca, Marco, et al.
Publicado: (2014)

Signalling Properties of Inositol Polyphosphates
por: Maffucci, Tania, et al.
Publicado: (2020)

Comprehensive Gene Expression Analysis to Identify Differences and Similarities between Sex- and Stage-Stratified Melanoma Samples
por: Chrysanthou, Eirini, et al.
Publicado: (2022)

Phosphoinositide 3-Kinase-Dependent Signalling Pathways in Cutaneous Squamous Cell Carcinomas
por: Janus, Joanna M., et al.
Publicado: (2017)

Activity of Pan-Class I Isoform PI3K/mTOR Inhibitor PF-05212384 in Combination with Crizotinib in Ovarian Cancer Xenografts and PDX()
por: Iezzi, Alice, et al.
Publicado: (2016)

Growth and Viability of Cutaneous Squamous Cell Carcinoma Cell Lines Display Different Sensitivities to Isoform-Specific Phosphoinositide 3-Kinase Inhibitors
por: Mannella, Viviana, et al.
Publicado: (2021)

p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis
por: Matin, Rubeta N., et al.
Publicado: (2013)

Gene and microRNA modulation upon trabectedin treatment in a human intrahepatic cholangiocarcinoma paired patient derived xenograft and cell line
por: Peraldo Neia, Caterina, et al.
Publicado: (2016)

3-Phosphoinositide-dependent protein kinase-1 as an emerging target in the management of breast cancer
por: Fyffe, Chanse, et al.
Publicado: (2013)

Correction: mTrop1/Epcam Knockout Mice Develop Congenital Tufting Enteropathy through Dysregulation of Intestinal E-cadherin/β-catenin
por: Guerra, Emanuela, et al.
Publicado: (2013)

mTrop1/Epcam Knockout Mice Develop Congenital Tufting Enteropathy through Dysregulation of Intestinal E-cadherin/β-catenin
por: Guerra, Emanuela, et al.
Publicado: (2012)

Cells with stemness features are generated from in vitro transformed human fibroblasts
por: Bono, Bartolo, et al.
Publicado: (2018)

Class (I) Phosphoinositide 3-Kinases in the Tumor Microenvironment
por: Gyori, David, et al.
Publicado: (2017)

p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading
por: Guerra, Emanuela, et al.
Publicado: (2016)

Vav1 downmodulates Akt in different breast cancer subtypes: a new promising chance to improve breast cancer outcome
por: Grassilli, Silvia, et al.
Publicado: (2018)

A novel inhibitor of the PI3K/Akt pathway based on the structure of inositol 1,3,4,5,6-pentakisphosphate
por: Falasca, M, et al.
Publicado: (2010)

A Small Molecule Inhibitor of PDK1/PLCγ1 Interaction Blocks Breast and Melanoma Cancer Cell Invasion
por: Raimondi, Claudio, et al.
Publicado: (2016)

Alterations of MEN1 and E-cadherin/β-catenin complex in sporadic pulmonary carcinoids
por: VESCHI, SERENA, et al.
Publicado: (2012)

Class I and class III phosphoinositide 3-kinases are required for actin polymerization that propels phagosomes
por: Bohdanowicz, Michal, et al.
Publicado: (2010)

High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma
por: Curia, Maria Cristina, et al.
Publicado: (2019)

A novel and selective PDK1 inhibitor reduces breast cancer cell invasion and tumour growth
por: Raimondi, C, et al.
Publicado: (2010)

Dual tumor suppressing and promoting function of Notch1 signaling in human prostate cancer
por: Lefort, Karine, et al.
Publicado: (2016)

Inhibition of the Lysophosphatidylinositol Transporter ABCC1 Reduces Prostate Cancer Cell Growth and Sensitizes to Chemotherapy
por: Emmanouilidi, Aikaterini, et al.
Publicado: (2020)

Gene Expression Signature Predictive of Neuroendocrine Transformation in Prostate Adenocarcinoma
por: Ostano, Paola, et al.
Publicado: (2020)

Effects of Dietary Supplementation of Carnosine on Mitochondrial Dysfunction, Amyloid Pathology, and Cognitive Deficits in 3xTg-AD Mice
por: Corona, Carlo, et al.
Publicado: (2011)

The 2EF Antibody Targets a Unique N-Terminal Epitope of Trop-2 and Enhances the In Vivo Activity of the Cancer-Selective 2G10 Antibody
por: Guerra, Emanuela, et al.
Publicado: (2023)

Dysregulation of Phosphoinositide 5-Phosphatases and Phosphoinositides in Alzheimer's Disease
por: Ando, Kunie, et al.
Publicado: (2021)

Essential Role of the p110β Subunit of Phosphoinositide 3-OH Kinase in Male Fertility
por: Ciraolo, Elisa, et al.
Publicado: (2010)

Phosphoinositides and phagocytosis
por: Gillooly, David J., et al.
Publicado: (2001)

Loss of Class III Phosphoinositide 3-Kinase Vps34 Results in Cone Degeneration
por: Rajala, Ammaji, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i4uuffa3dpvf9jjlqk0lfurona